{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:12:32Z","timestamp":1761059552595},"reference-count":11,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.53","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T23:26:52Z","timestamp":1371770812000},"page":"53-56","source":"Crossref","is-referenced-by-count":17,"title":["A Case of IgG4-Related Dacryoadenitis that Regressed Without Systemic Steroid Administration"],"prefix":"10.3960","volume":"53","author":[{"given":"Koh-ichi","family":"Ohshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Khosroshahi A, Stone JH: Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 23:67-71, 2011","DOI":"10.1097\/BOR.0b013e328341a240"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Khosroshahi A, Bloch DB, Deshpande V, Stone JH: Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755-1762, 2010","DOI":"10.1002\/art.27435"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Murakami J, Matsui S, Ishizawa S, Arita K, Wada A, <I>et al<\/I>.: Recurrence of IgG4-related disease following treatment with rituximab. Mod Rheumatol [2012 Sep 6. DOI:10.1007\/s10165-012-0738-2]","DOI":"10.1007\/s10165-012-0738-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, <I>et al<\/I>.: Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181-1192, 2012","DOI":"10.1038\/modpathol.2012.72"},{"key":"5","unstructured":"5 Murazaki M, Mishima H, Miyachi Y: Ocular steroid therapies. 1. Plasma betamethasone level after topical application to eyes. Nihon Ganka Gakkai Zasshi 82:63-67, 1978 (<I>in Japanese<\/I>)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Miyachi Y, Yotsumoto H, Kano T, Mizuchi A, Muto T, <I>et al<\/I>.: Blood levels of synthetic glucocorticoids after administration by various routes. J Endocrinol 82:149-157, 1979","DOI":"10.1677\/joe.0.0820149"},{"key":"7","unstructured":"7 F&uuml;gner A, Bechtel WD, Kuhn FJ, Mierau J: <I>In vitro<\/I> and <I>in vivo<\/I> studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 38:1446-1453, 1988"},{"key":"8","unstructured":"8 Tasaka K, Akagi M, Izushi K, Aoki I: Antiallergic effect of epinastine : the elucidation of the mechanism. Pharmacometrics 39:365-373, 1990"},{"key":"9","unstructured":"9 Kamei C, Akagi M, Mio M, Kitazumi K, Izushi K, <I>et al<\/I>.: Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions : (I). Elucidation of the mechanism for histamine release inhibition. Immunopharmacol Immunotoxicol 14:191-205, 1992"},{"key":"10","unstructured":"10 Kamei C, Mio M, Kitazumi K, Tsujimoto S, Yoshida T, <I>et al<\/I>.: Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions : (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects. Immunopharmacol Immunotoxicol 14:207-218, 1992"},{"key":"11","unstructured":"11 Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, <I>et al<\/I>.: IgG4-related disease : Historical overview and pathology of hematological disorders. Pathol Int 60:247-258, 2010"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T23:45:28Z","timestamp":1645832728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/1\/53_53\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.53","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}